These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Cognate T cell help for CD40-deficient B cells induces c-myc RNA expression, but DNA synthesis requires an additional signal through surface Ig. Schrader CE; Stavnezer J; Kikutani H; Parker DC J Immunol; 1997 Jan; 158(1):153-62. PubMed ID: 8977186 [TBL] [Abstract][Full Text] [Related]
6. The B cell antigen receptor and overexpression of MYC can cooperate in the genesis of B cell lymphomas. Refaeli Y; Young RM; Turner BC; Duda J; Field KA; Bishop JM PLoS Biol; 2008 Jun; 6(6):e152. PubMed ID: 18578569 [TBL] [Abstract][Full Text] [Related]
7. Antigen selection in B-cell lymphomas--tracing the evidence. Sutton LA; Agathangelidis A; Belessi C; Darzentas N; Davi F; Ghia P; Rosenquist R; Stamatopoulos K Semin Cancer Biol; 2013 Dec; 23(6):399-409. PubMed ID: 23932942 [TBL] [Abstract][Full Text] [Related]
8. Requirements for control of B-cell lymphoma by NK cells. Brenner CD; King S; Przewoznik M; Wolters I; Adam C; Bornkamm GW; Busch DH; Röcken M; Mocikat R Eur J Immunol; 2010 Feb; 40(2):494-504. PubMed ID: 19950185 [TBL] [Abstract][Full Text] [Related]
9. Intensive immunochemotherapy for high-risk aggressive B-cell lymphomas: MYC-rearrangements and beyond. Hsi ED Lancet Haematol; 2018 Dec; 5(12):e600-e601. PubMed ID: 30501862 [No Abstract] [Full Text] [Related]
10. Atypical B cell receptor signaling: straddling immune diseases and cancer. Faris M Int Rev Immunol; 2013 Aug; 32(4):355-7. PubMed ID: 23848467 [TBL] [Abstract][Full Text] [Related]
11. Signaling of programmed cell death induction in WEHI-231 B lymphoma cells. Hibner U; Benhamou LE; Haury M; Cazenave PA; Sarthou P Eur J Immunol; 1993 Nov; 23(11):2821-5. PubMed ID: 8223858 [TBL] [Abstract][Full Text] [Related]
13. Signaling properties of anti-immunoglobulin--resistant variants of WEHI-231 B lymphoma cells. Benhamou LE; Watanabe T; Kitamura D; Cazenave PA; Sarthou P Eur J Immunol; 1994 Sep; 24(9):1993-9. PubMed ID: 8088319 [TBL] [Abstract][Full Text] [Related]
14. Monoclonal antibody, LR-2, recognizes an immunoglobulin-linked signaling molecule on murine B cells. Marshall-Clarke S; Greenwood M Cell Immunol; 1994 Feb; 153(2):428-42. PubMed ID: 8118874 [TBL] [Abstract][Full Text] [Related]
15. Insertion of c-Myc into Igh induces B-cell and plasma-cell neoplasms in mice. Park SS; Kim JS; Tessarollo L; Owens JD; Peng L; Han SS; Tae Chung S; Torrey TA; Cheung WC; Polakiewicz RD; McNeil N; Ried T; Mushinski JF; Morse HC; Janz S Cancer Res; 2005 Feb; 65(4):1306-15. PubMed ID: 15735016 [TBL] [Abstract][Full Text] [Related]
16. The pre-BCR checkpoint as a cell-autonomous proliferation switch. Hendriks RW; Middendorp S Trends Immunol; 2004 May; 25(5):249-56. PubMed ID: 15099565 [No Abstract] [Full Text] [Related]
17. The road to the production of IgE is long and winding. Karnowski A; Yu P; Achatz G; Lamers MC Am J Respir Crit Care Med; 2000 Sep; 162(3 Pt 2):S71-5. PubMed ID: 10988155 [No Abstract] [Full Text] [Related]
18. T helper cell regulation of normal and neoplastic B cell growth. Snow EC; Pittner B; Reid S Semin Immunol; 1994 Oct; 6(5):311-26. PubMed ID: 7865801 [TBL] [Abstract][Full Text] [Related]
19. Regulation of BCR signaling. Kurosaki T Mol Immunol; 2011 Jun; 48(11):1287-91. PubMed ID: 21195477 [TBL] [Abstract][Full Text] [Related]
20. Autoimmunity checkpoints as therapeutic targets in B cell malignancies. Müschen M Nat Rev Cancer; 2018 Feb; 18(2):103-116. PubMed ID: 29302068 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]